Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


16.07.2018

1 ACS Appl Mater Interfaces
1 Biomed Res Int
1 Biosens Bioelectron
1 BJU Int
1 Br J Cancer
2 Can Urol Assoc J
1 Cell Physiol Biochem
1 Chem Biol Interact
1 Clin Cancer Res
1 Clin Genitourin Cancer
1 Drug Des Devel Ther
1 Eur J Surg Oncol
1 Histopathology
1 Int J Cancer
1 Int J Nanomedicine
1 Int J Urol
1 Investig Clin Urol
2 J BUON
1 J Med Ultrason (2001)
1 Lancet
1 Mol Ther Oncolytics
1 Nat Rev Urol
1 Oncotarget
1 Prog Urol
11 Tumori
1 World J Urol
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    ACS Appl Mater Interfaces

  1. ZHANG D, Wang Z, Wang L, Wang Z, et al
    High-Performance Identification of Human Bladder Cancer Using Signal Self-Amplifiable Photoacoustic Nanoprobe.
    ACS Appl Mater Interfaces. 2018 Jul 10. doi: 10.1021/acsami.8b08357.
    PubMed     Text format     Abstract available


    Biomed Res Int

  2. FALKE J, Parkkinen J, Vaahtera L, Hulsbergen-van de Kaa CA, et al
    Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.
    Biomed Res Int. 2018;2018:9634902.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  3. ARYA SK, Estrela P
    Electrochemical ELISA-based platform for bladder cancer protein biomarker detection in urine.
    Biosens Bioelectron. 2018;117:620-627.
    PubMed     Text format     Abstract available


    BJU Int

  4. SMITH A, Daneshmand S, Patel S, Pohar K, et al
    Patient-reported Outcomes of Blue Light Flexible Cystoscopy with Hexaminolevulinate (HAL) in the Surveillance of Bladder Cancer: Results from a Prospective Multi-center Study.
    BJU Int. 2018 Jul 6. doi: 10.1111/bju.14481.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. SMITTENAAR P, Walker AK, McGill S, Kartsonaki C, et al
    Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer.
    Br J Cancer. 2018 Jul 11. pii: 10.1038/s41416-018-0156.
    PubMed     Text format     Abstract available


    Can Urol Assoc J

  6. DO J, Lee SW, Jeh SU, Hwa JS, et al
    Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence.
    Can Urol Assoc J. 2018 Jun 8. pii: cuaj.5122. doi: 10.5489/cuaj.5122.
    PubMed     Text format     Abstract available

  7. MCALPINE K, Fergusson DA, Breau RH, Reynolds LF, et al
    Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.
    Can Urol Assoc J. 2018 May 28. pii: cuaj.5244. doi: 10.5489/cuaj.5244.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  8. LIU X, Liu X, Wu Y, Fang Z, et al
    MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Cell Physiol Biochem. 2018;48:87-98.
    PubMed     Text format     Abstract available


    Chem Biol Interact

  9. ZHANG M, Du H, Huang Z, Zhang P, et al
    Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway.
    Chem Biol Interact. 2018 Jul 2. pii: S0009-2797(18)30167.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. LI Q, Damish A, Frazier ZJ, Liu D, et al
    ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jul 6. pii: 1078-0432.CCR-18-1001.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  11. SOUBRA A, Gencturk M, Froelich J, Balaji P, et al
    FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients.
    Clin Genitourin Cancer. 2018 May 31. pii: S1558-7673(18)30344.
    PubMed     Text format     Abstract available


    Drug Des Devel Ther

  12. KARAVANA SY, Senyigit ZA, Caliskan C, Sevin G, et al
    Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
    Drug Des Devel Ther. 2018;12:1959-1975.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  13. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Text format     Abstract available


    Histopathology

  14. DE JONG JJ, Stoop H, Nieboer D, Boormans JL, et al
    Concordance of PD-L1 expression in matched urothelial bladder cancer specimens.
    Histopathology. 2018 Jul 12. doi: 10.1111/his.13710.
    PubMed     Text format     Abstract available


    Int J Cancer

  15. KOUTROS S, Baris D, Waddell R, Freeman LEB, et al
    Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31720.
    PubMed     Text format     Abstract available


    Int J Nanomedicine

  16. HU B, Yan Y, Tong F, Xu L, et al
    Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer.
    Int J Nanomedicine. 2018;13:3625-3640.
    PubMed     Text format     Abstract available


    Int J Urol

  17. NAKAI Y, Inoue K, Tsuzuki T, Shimamoto T, et al
    Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
    Int J Urol. 2018 Jul 12. doi: 10.1111/iju.13718.
    PubMed     Text format     Abstract available


    Investig Clin Urol

  18. YILMAZ Y, Kahya MC, Dilek FH, Kose O, et al
    Can tumor recurrence be reduced with plasma-kinetic vaporization of the area around the tumor in nonmuscle invasive bladder cancer?
    Investig Clin Urol. 2018;59:223-231.
    PubMed     Text format     Abstract available


    J BUON

  19. ZHONG X, Long Z, Wu S, Xiao M, et al
    LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
    J BUON. 2018;23:776-781.
    PubMed     Text format     Abstract available

  20. TANG Z
    Effects of human enhancer of filamentation 1 (HEF1) gene on the proliferation, invasion and metastasis of bladder cancer cells.
    J BUON. 2018;23:782-786.
    PubMed     Text format     Abstract available


    J Med Ultrason (2001)

  21. YOSHIMURA H, Okano T, Inui K, Nakamura H, et al
    Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer.
    J Med Ultrason (2001). 2018 Jul 10. pii: 10.1007/s10396-018-0889.
    PubMed     Text format     Abstract available


    Lancet

  22. PAREKH DJ, Reis IM, Castle EP, Gonzalgo ML, et al
    Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
    Lancet. 2018;391:2525-2536.
    PubMed     Text format     Abstract available


    Mol Ther Oncolytics

  23. ANNELS NE, Arif M, Simpson GR, Denyer M, et al
    Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus.
    Mol Ther Oncolytics. 2018;9:1-12.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  24. PETTENATI C, Ingersoll MA
    Mechanisms of BCG immunotherapy and its outlook for bladder cancer.
    Nat Rev Urol. 2018 Jul 10. pii: 10.1038/s41585-018-0055.
    PubMed     Text format     Abstract available


    Oncotarget

  25. PANDEY S, Bourn J, Cekanova M
    Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells.
    Oncotarget. 2018;9:28514-28531.
    PubMed     Text format     Abstract available


    Prog Urol

  26. MICHEL C, Vordos D, Dumont C, Basset V, et al
    [Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer].
    Prog Urol. 2018 Jul 8. pii: S1166-7087(18)30169.
    PubMed     Text format     Abstract available


    Tumori


  27. 9 - Tossicita Da Trattamento Radioterapico E Da Terapia Sistemica Per Neoplasia Vescicale.
    Tumori. 2018;104.
    PubMed     Text format    


  28. 3 - Diagnosi E Stadiazione.
    Tumori. 2018;104.
    PubMed     Text format    


  29. 4 - Trattamento Chirurgico Della Malattia Non Muscolo-Invasiva (NMIBC).
    Tumori. 2018;104.
    PubMed     Text format    


  30. 5 - Trattamento Chirurgico Della Malattia Muscolo-Invasiva E Localmente Avanzata (MIBC).
    Tumori. 2018;104.
    PubMed     Text format    


  31. 7 - Terapia Nella Malattia In Progressione E Metastatica.
    Tumori. 2018;104.
    PubMed     Text format    


  32. 2 - Epidemiologia E Classificazione Istopatologica.
    Tumori. 2018;104.
    PubMed     Text format    


  33. 11 - Follow-Up.
    Tumori. 2018;104.
    PubMed     Text format    


  34. Linee Guida AIRO-AIRB 2018: Neoplasie della Vescica.
    Tumori. 2018;104.
    PubMed     Text format    


  35. 10 - Nuove Tecnologie in Radioterapia E Prospettive Future.
    Tumori. 2018;104.
    PubMed     Text format    


  36. 6 - Terapia Trimodale Nel Trattamento Conservativo Della Neoplasia Vescicale.
    Tumori. 2018;104.
    PubMed     Text format    


  37. 8 - Pianificazione E Somministrazione Del Trattamento Radioterapico.
    Tumori. 2018;104.
    PubMed     Text format    


    World J Urol

  38. FERRO M, Vartolomei MD, Russo GI, Cantiello F, et al
    An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
    World J Urol. 2018 Jul 10. pii: 10.1007/s00345-018-2397.
    PubMed     Text format     Abstract available


    Zhonghua Zhong Liu Za Zhi

  39. LIU ZH, Shi JY, Wang HY, Ye HY, et al
    [CT texture analysis in bladder carcinoma: histologic grade characterization].
    Zhonghua Zhong Liu Za Zhi. 2018;40:379-383.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: